Frank J. Lane
Direttore/Membro del Consiglio presso ALBERT LABS INTERNATIONAL CORP.
Profilo
Frank J.
Lane is the founder of Cfn Media, which was founded in 2013, where he holds the title of President.
Currently, he holds the position of Director at Albert Labs, Inc. and Albert Labs International Corp.
Additionally, he is the President & Executive Officer-CFN Media at CFN Enterprises, Inc. since 2019.
Mr. Lane received his undergraduate degree from Seattle University in 1989.
Posizioni attive di Frank J. Lane
| Società | Posizione | Inizio |
|---|---|---|
| CFN ENTERPRISES INC. | Corporate Officer/Principal | 01/06/2019 |
| ALBERT LABS INTERNATIONAL CORP. | Direttore/Membro del Consiglio | - |
| Cfn Media | Fondatore | 01/01/2013 |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Direttore/Membro del Consiglio | - |
Formazione di Frank J. Lane
| Seattle University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CFN ENTERPRISES INC. | Technology Services |
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
| Cfn Media | |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
- Borsa valori
- Insiders
- Frank J. Lane
